4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-22-046488
SVP & General Counsel sold 3,189 shares at $4.76 ($15,180)
- SVP & General Counsel acquired 165,938 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Wilson Mark Andrew SVP & General Counsel | 2022-08-15 | Grant or award | +165,938 | 284,377 | D | ||
| Wilson Mark Andrew SVP & General Counsel | 2022-08-16 | Sale | −3,189 | $4.76 | $15,180 | 281,188 | D |
| Derivatives | |||||||
| Wilson Mark Andrew SVP & General Counsel | 2022-08-15 | Grant or award · Common Stock | +331,875 | 331,875 | D | ||
| Open-market sales · 3,189 sh · avg $4.76 · $15,180 | |||||||
Loading xslF345X03/doc4.xml…